Latest Articles

  • Giant cell arteritis: An updated review of an old disease
    Timothy Rinden, DO, Eric Miller, MD and Rawad Nasr, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 465-472; DOI: https://doi.org/10.3949/ccjm.86a.18103

    Glucocorticoids, the mainstay of treatment, should be started as soon as the disease is suspected.

  • Infertility: A practical framework
    Rebecca Flyckt, MD and Tommaso Falcone, MD, FRCSC, FACOG
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 473-482; DOI: https://doi.org/10.3949/ccjm.86a.18068

    Frequently asked questions and a practical framework for approaching the infertile couple.

  • Pediatric cholestatic liver disease: Successful transition of care
    Pediatric cholestatic liver disease: Successful transition of care
    Praveen Kumar Conjeevaram Selvakumar, MD, Vera Hupertz, MD, Naveen Mittal, MD, Kris V. Kowdley, MD and Naim Alkhouri, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 454-464; DOI: https://doi.org/10.3949/ccjm.86a.18140

    Many more children with liver disease are surviving into adulthood and transitioning to adult care.

  • Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?
    Joy-Ann Tabanor, MBBS and Santhanam Lakshminarayanan, MBBS
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 449-453; DOI: https://doi.org/10.3949/ccjm.86a.18084

    Consider it in those with granulomatosis with polyangiitis or pulmonary disease, or those on high-dose steroids.

  • Clinical trials: More to learn than the results
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 437-438; DOI: https://doi.org/10.3949/ccjm.86b.07019

    The details of the GIACTA trial challenge and reaffirm some of our clinical impressions about giant cell arteritis.

  • Type 2 diabetes: Evolving concepts and treatment
    Eden Miller, DO, Richard B. Aguilar, MD, Mary E. Herman, PhD and Stanley S. Schwartz, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 494-504; DOI: https://doi.org/10.3949/ccjm.86a.17107

    Preserving beta cells is key. Recent studies provide compelling argument regarding treatments of choice.

  • Thinker’s sign
    Renée Grandjean, MD and Lars C. Huber, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 439; DOI: https://doi.org/10.3949/ccjm.86a.19036

    In a patient with orthopnea, pressure of the elbows on the thighs can cause hyperpigmentation and skin thickening.

  • If a picture is worth a thousand words, a patient is worth ten thousand
    Paul Aronowitz, MD, MACP
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 443-444; DOI: https://doi.org/10.3949/ccjm.86a.19070

    Images portray real patients with stories to tell, sometimes mundane, sometimes profound, but always worth hearing.

  • Women’s health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy
    Anna Camille Moreno, DO, NCMP, Sabrina Kaur Sahni, MD, NCMP, Taryn L. Smith, MD and Pelin Batur, MD, FACP, NCMP, CCD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 400-406; DOI: https://doi.org/10.3949/ccjm.86a.18130

    Vignettes with practical advice based on current literature.

  • A sleeping beast: Obstructive sleep apnea and stroke
    Zachary McKee, BS and Dennis H. Auckley, MD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 407-415; DOI: https://doi.org/10.3949/ccjm.86a.18033

    Up to two-thirds of patients who have had a stroke have obstructive sleep apnea afterward, with worse outcomes.

Pages